Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

May 15, 2018 - 10:58 a.m.
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in AdolescentsPrinter Friendly Version 
May 15, 2018 - 8:32 a.m.
Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy PipelinePrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 05/19/18
1.SEC Filings
2.Annual Reports
3.Earnings
4.Fundamentals - Snapshot
5.Stock Information
* Data collected 05/11/18 - 05/18/18

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$67.63
 Stock is Down 0.39 (0.57%)
Data as of 05/21/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the Bank of America Merrill Lynch Healthcare Conference

May 16, 2018 9:20 a.m. PT
Play
2018 Annual Meeting of Stockholders

May 09, 2018 10:00 a.m. PT
Play
First Quarter 2018 Gilead Sciences Earnings Conference Call

May 01, 2018 1:30 p.m. PT
Play
Gilead Sciences at the RBC Capital Markets 2018 Global Healthcare Conference

February 21, 2018 9:00 a.m. ET
Play